Molecule
Canrenoic acid; LC-ESI-Q; MS; NEG; 30 V
Canrenoic acid; LC-ESI-Q; MS; POS; 15 V, 30 V
Canrenoic acid; LC-ESI-Q; MS; POS; 45 V
Canrenoic acid; LC-ESI-Q; MS; POS; 60 V
Canrenoic acid; LC-ESI-Q; MS; POS; 75 V, 90 V
3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid
Chemical Information
5 Related Dataset(s)
⌄
Metadata Information
| Field | Value |
|---|---|
| NFDI4Chem Molecule ID | nfdi4chem-mol76560 |
| Source | |
| Alternate Name |
| Field | Value |
|---|---|
| No additional information available for this Dataset. | |
| Data-Source Molecule ID | Data-Source |
|---|---|
| SCHEMBL636758 | SureChEMBL |
| ZINC000003938750 | ZINC |
| 35867163 | eMolecules |
| 4138-96-9 | ACToR |
| LSM-3029 | LINCS |
| canrenoate | Atlas |
| 656615 | PubChem |
| 15076866 | PubChem: Thomson Pharma |
| 87UG89VA9K | FDA SRS |
| PD014514 | ProbesDrugs |
| CHEMBL1616951 | ChEMBL |
| 50156 | ChEBI |
| DB09015 | DrugBank |
| DTXSID5022726 | EPA CompTox Dashboard |
| 477 | DrugCentral |
| LMST02030154 | LipidMaps |
| J8.683E | Nikkaji |
| CANRENOIC ACID | rxnorm |
| POTASSIUM CANRENOATE | clinicaltrials |
| CANRENOATE | rxnorm |
| SOLDACTONE | clinicaltrials |
| SC-14266 | clinicaltrials |
| CANRENOATE | clinicaltrials |
| CANRENOATE POTASSIUM | clinicaltrials |
| CANRENOIC ACID | clinicaltrials |
| CANRENOATE POTASSIUM | rxnorm |
| The data in this table is sourced from UniChem at EBI. | |